Form 8-K - Current report:
SEC Accession No. 0001104659-21-088918
Filing Date
2021-07-02
Accepted
2021-07-02 16:33:07
Documents
3
Period of Report
2021-06-29
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2121331d1_8k.htm 8-K 21519
2 EXHIBIT 3.1 tm2121331d1_ex3-1.htm EX-3.1 38174
3 EXHIBIT 3.2 tm2121331d1_ex3-2.htm EX-3.2 129451
  Complete submission text file 0001104659-21-088918.txt   190304
Mailing Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116
Business Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40544 | Film No.: 211070681
SIC: 2834 Pharmaceutical Preparations